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Abstract 
Cancer patients often have to deal with numerous side effects and psychological distress during chemotherapy. Research has 
shown that dysfunctional metacognitive beliefs are the basis for the development and maintenance of emotional disorders. The 
present research is a first attempt to explore how metacognitions influence anxiety and depression in cancer patients undergoing 
chemotherapy. A sample of 175 cancer patients undergoing chemotherapy completed a demographic questionnaire, the 
Metacognitions Questionnaire-30 (MCQ-30)and the Hospital Anxiety and Depression Scale (HADS). Medical information about 
the stage of disease and the history of treatment was obtained.  Linguistic  analysis (Stansfield et al 1992) was employed  to 
ensure that the form had been correctly translated because the Italian form of  the MCQ-30 was utilized (Quattropani, et.al, 2014) 
Negative beliefs, the need to control thoughts, and positive beliefs explained up to 89% of variance of anxiety in cancer patients 
during chemotherapy.  The negative beliefs about worry and the gender explained up to 81% of variance of depression in cancer 
patients during chemotherapy. In fact, female gender was positively correlated with depression level of patients. The negative 
beliefs about worry and the need to control thoughts explained the 81% variance for the overall distress of patients during 
chemotherapy. In conclusion, some metacognitive factors have a crucial role both for anxiety and depression in cancer patients 
ongoing chemotherapy. It is suggested that the psychological intervention for cancer patients should assess such factors and try to 
address them in clinical practice. 
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1. Problem Statement 
Patients confronted with a diagnosis of cancer face many problems: physical symptoms, psychological reactions 
of fear, sadness and preoccupation for the family and their future, and the search for a tolerable meaning for the 
disease in the  spiritual domain (Holland, 2003). Patients and family members can suffer from clinical levels of 
depression and severe levels of anxiety and stress reactions (Edwards and Clarke, 2004). Cancer patients often have 
to deal with numerous side effects and psychological distress during chemotherapy, often resulting in a decrease in 
the patients’ quality of life (Luebbert et al., 2001) . However, not much is known about mood disorders in cancer 
patients.  
   Results of meta-analysis have demonstrated the great impact of depression on mortality in cancer patients but 
not on mortality.  (Satin et al., 2009). In particular, depression is strongly associated with mortality in younger 
patients with early stage breast cancer (Vodermaier et al., 2014).  
   Nevertheless, the overall prevalence rate of depression reported in literature remains uncertain. Varying 
conceptualizations of depression, different criteria used to define depression, differences in methodological 
approaches to the measurement of depression, and different populations studied can explain the differences of 
results (Massie, 2004). 
   Anxiety-based symptoms in response to a cancer diagnosis often occur in patients. The prevalence of anxiety 
and resulting depression with a cancer diagnosis is unclear. Reasons for these significant differences in literature 
include the definition of morbid anxiety, the range of self-report measures being applied without a clear 
understanding of their relation to morbid anxiety, social or demographic factors, and aspects of cancer diagnosis and 
treatment (Stark et al., 2002).  The results of a recent meta-analysis pointed out the following:  the prevalence of all 
types of depression occurred in 20.7% of patients, depression or adjustment disorder occurred in 31.6% , and any 
other  mood disorder in 38.2% (Mitchell et al., 2011).  
   In the last decades, significant research has demonstrated that a subgroup of chemotherapy patients is 
vulnerable to post-treatment cognitive changes, even though not exclusively correlated to chemotherapy. Results of 
a recent review showed that cognitive changes associated with cancer and cancer treatments can be viewed in the 
context of factors that affect the trajectory of normal aging (Ahles, 2012).  However, there is no association between 
subjective and objective evaluations of cognitive functioning for patients in cancer treatment. In fact, 
neuropsychological compromise and self-perceived cognitive dysfunction are independent phenomena in cancer 
patients (Hermelink et al., 2010). 
   On the basis of these two different sides of psychological factors involved in cancer patients undergoing 
chemotherapy, a thorough understanding of the cognitive functioning of these patients is necessary. In fact, studies 
from many fields of research have shown that an integrated psychological and medical approach together increase 
the efficacy of the treatments (Lenzo and Quattropani, 2013). 
   Regarding the role of metacognitions, many lines of evidence indicate that there is a strong relationship 
between emotional processes, cognition, metacognitive beliefs and behaviors. In this perspective, Wells and Purdon 
(Wells and Purdon, 1999) define metacognition as “the aspect of information processing that monitors, interprets, 
evaluates and regulates the contents and processes of its organization”. According to Wells’ theoretical model, 
dysfunctional metacognitive beliefs are the basis for the development and maintenance of psychological disorders 
(Wells, 1996). In particular, vulnerability and psychological maintenance of disorder are associated with a non-
specific style of thinking which is known as the Cognitive-Attentional Syndrome (CAS) (Wells, 2007, 2009). In 
fact, CAS consists of positive beliefs about worry, negative beliefs about worry concerning uncontrollability and 
danger, and cognitive resource limitations and beliefs about the need to control thoughts. Wells constructed a 
metacognitive theory for emotional disorders, and also developed self-reporting instruments for assessing 
dysfunctional beliefs.  
   The Metacognitions Questionnaire (MCQ) and its short version (MCQ-30) both are measures for a range of 
metacognitive beliefs and processes relevant to vulnerability and maintenance of emotional disorders (Catwright-
Hatton and  Wells, 1997, Wells and Cartwright-Hatton, 2004). The short version (Wells and Cartwright-Hatton, 
2004) of  the Metacognitions Questionnaire (Catwright-Hatton and  Wells, 1997) was chosen to assess dysfunctional 
metacognitive beliefs because it is the quickest and most utilized instrument in the area of metacognitions research. 
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Moreover, it assesses some related metacognition factors that could be critical in cancer patients undergoing 
chemotherapy. 
If there are emotional disorders related to anxiety and depression, they can increase dysfunctional metacognitive 
beliefs resulting in a further increase in anxiety and depression.  Regarding the assessment of anxiety and depression 
symptoms, Hospital Anxiety and Depression Scale (Zigmond and Snaith 1983, 1994) was chosen because it is 
widely employed in the cancer literature (Costantini et al., 1999). A clinical group of patients undergoing 
chemotherapy participated in this study and the hypothesis was examined. 
2. Purpose of Study 
The goal was to examine the relationships between metacognitive beliefs, anxiety, and depression during 
chemotherapy. The hypothesis that significant and positive correlations exist between some metacognitive factors, 
anxiety, and depression was the basis of this research.   
3. Methods 
3.1. Participants 
A sample of 175 cancer patients undergoing chemotherapy in an oncological department of a university hospital 
in southern Italy participated in this study. All patients were native Italian speakers and Italian nationals. Socio-
demographics and medical characteristics of the sample are presented in Table 1. The sample consists of 141 women 
(81%) and 34 men (19%). The mean age was 58.21 years (SD = 11.66; range = 27-85), and the level of education in 
years was 10.87 (SD = 4.39; mode = 13; median = 13).  Sixty-six percent were married, and in terms of occupation, 
69% were unemployed. 
With regards to medical status, patients had been diagnosed with various forms of cancer. Most of them reported 
a diagnosis of breast cancer (46%). Other diagnoses included colorectal (30%) and other (24%). The majority of the 
patients (89%) had cancer in stage I. Thirty-three percent of the patients had been undergoing chemotherapy for 6 
months (mean = 8.40; SD = 9.63). 
Exclusion criteria included pre-existing psychopathology or neurological disorders that would interfere with the 
completion of the measures. 
 
Table 1. Demographic and medical characteristics of the sample  
 
Demographic and medical characteristics % Mean (SD) 
 
Age  58.21 (11.66) 
 
Gender 
   Male 
   Female 
 
19 
81 
 
 
Status 
   Single (or separated/widowed) 
   Married 
 
34 
66 
 
 
Education 
   Less than high school 
   High school or more 
 
  
 
Employment status 
   Employed 
   Unemployed 
 
69 
31 
 
 
Type of cancer 
   Breast 
 
46 
54 
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   Colon and other 
 
Stage 
   I 
   II and III 
 
89 
11 
 
 
Months undergoing chemotherapy  8.40(9.63) 
 
3.2. Measures 
The following data was gathered and then statistically analysed:   
1. Socio-demographic information including age, gender, educational degree, nationality, marital status; 
2. Medical information including data on the stage of the disease and treatment history; 
3. Metacognitions Questionnaire-30 (Wells and Catwright-Hatton, 2004). This is a 30-item, self-reporting 
questionnaire, which measures a range of metacognitive beliefs and processes relevant to vulnerability and 
maintenance of emotional disorders. The items are rated on a 4-point Likert scale from 1 (‘do not agree’) to 4 
(‘completely agree’). The items are grouped into five subscales, as in the original version (Cartwright-Hatton and 
Wells, 1997). Factorial analysis of this questionnaire has identified five factors: cognitive confidence, which 
measures confidence in attention and memory (Cognitive confidence, CC); cognitive self-consciousness, which 
measures the tendency to monitor one’s own thoughts and focus attention inward (Cognitive self-consciouness, 
CSC), positive beliefs about worry, which measures the extent to which a person thinks that perseverative thinking 
is useful (Positive beliefs about worry, POS), negative beliefs about worry concerning uncontrollability and danger, 
which assess the extent to which a person thinks that perseverative thinking is uncontrollable and dangerous 
(Negative beliefs about uncontrollability and danger, NEG), beliefs about the need to control thoughts, which 
assesses the extent to which a person believes that certain types of thoughts need to be suppressed (Need to control 
thoughts, NC). All items refer to  general ideas and a high score on each factor is considered dysfunctional. The 
MCQ-30 is a brief, reliable and valid self-reporting measure of metacognitions (Wells and Catwright-Hatton, 2004; 
Spada et al., 2008). In this study, a validated Italian version of the MCQ-30 was used to assess metacognitive beliefs 
(Quattropani et al., 2014). Results of the Italian version of MCQ-30 indicated, as in the original version, direct 
correlations between metacognitive factors (except for CSC) and state and trait anxiety, pathological worry, and 
obsessive-compulsive symptoms. Reliability of all five factors in the present clinical group was acceptable to good, 
with Cronbach’s D ranging between 0.70 and 0.84 for the different scales. 
3.3. MCQ-30 validity for Italian translation 
Because the  MCQ-30 was originally written in English, and the present study was conducted in Italian, it was 
necessary to translate the instrument in a way that was both linguistically and culturally accurate. Comparable 
results and reliability depend on an accurate translation.  This section explains the process of translation. 
3.3.1. Translation defined 
 
Translating any document is a challenge, but the task of translating psychological test questions from one 
language and culture to another is a daunting feat. The literature regarding translation is almost endless: definitions 
of translation, procedure, technique, evaluation, checks for cultural accuracy...the list goes on and on.   Translation 
is defined as “the act or process of translation of something into a different language” (Merriam Webster, 2015).  R. 
Jacobson (1950) stated that “interlingual translation or translation proper is an interpretation of verbal signs by 
means of some other language”. Translation has also been defined as the “transfer of thoughts and ideas from one 
language (source) to another (target) (Brislin, 1976).  It is necessary to be able to understand and process the source 
language, in terms of syntax, “pragmatic understanding and analytical processing” (Newmark, 1981: p. 7).  Another 
consideration is the relationship between language and culture.  Due to the fact that culture is “the collective 
programming of the mind that distinguishes the members of one group or category of people from one another” 
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(Hofstede, 2000: p. 9) it seems obvious that language is the vehicle of culture and that culture would have an 
extremely strong impact on translation.  Culler (1976) stated that languages are not “nomenclatures” and because of 
this concepts can be radically different from language to language, since each language articulates experience 
differently, and languages do not simply name categories; they articulate their own (p.21-2).  Therefore, it seems 
logical to assume that core differences between languages add to the difficulty of rendering an accurate translation. 
Language is also a strong vehicle of cultural transmission, and culture and language are considered inseparable by 
many experts and researchers. 
3.3.2. Translation evaluation 
 
The literature contains varying definitions about what constitutes an accurate translation. According to the results 
of a study carried out for the U.S. Federal Bureau of Investigation (FBI) to create tests to evaluate translation ability, 
effective translation can be described in two words: accuracy and expression (Stansfield et al., 1992). Accuracy 
deals with the source document (SD) content transfer; expression includes form and linguistic quality.  The 
information from the source document (SD) must be transmitted into the target document (TG) as accurately as 
possible.  The term ‘as possible’ opens a debate between linguists and professional translators as to how close a 
translation can actually be to the original text. 
3.3.3. Error analysis 
 
Error analysis is a method  used in translation to ensure that accuracy is achieved to the maximum level.  It was 
employed to ensure that the MCQ-30 translation was as accurate as possible. The error analysis list used for this 
translation included (Hurtado Albir, 1995):  
• text comprehension errors (addition, omission, inappropriate linguistic variation, contradictions, 
meaningless expressions, mis-translation, misinterpretation)  
• expression errors: spelling, grammar, lexicon, text, style 
• function transmission errors 
3.3.4. Culture specific concepts 
 
Another important aspect of any translation is culture.  Culture-bound terms have been defined as terms referring 
to “concepts, institutions and personnel which are specific to the SL culture” (Harvey, (p.2), Harvey (2000:2-6).  
Newmark (1988, pp. 83) offered different techniques. His idea about ‘functional equivalent’ (use of a culture-neutral 
word) was appealing when doing this translation.  His idea of ‘shift’ or ‘transposition’ was also useful since English 
and Italian syntactical structures are frequently very different from each other. ‘Descriptive equivalent’ was also 
used when meanings had to be explained in several words and were not directly translatable (Harvey, 2000). 
3.3.5. Translation procedures for the MCQ-30 
 
The procedure for translating the MCQ-30 was based on a classical modal (Nida, 1964, pp.241-45). This 
procedure included analysis of the English source text, thorough study and comprehension of the questions and their 
underlying meaning. The target ‘audience’ and application was also considered.  Analysis of the semantic and 
syntactic structures was conducted. 
3.3.6. Summary of potential problem areas 
 
The English version of the MCQ-30 Short Form consists of five metacognitive areas (Factors) which measure 
beliefs, judgements and monitoring tendencies.  (Wells, Cartwright-Hatton, 2003).  The statements are composed of 
fairly short one-verb clauses.  A literal translation is not very difficult since the concepts and vocabulary used are 
quite simple and targeted to a general audience.  At first glance the translation appears to be very simple.  If in fact 
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all languages were nomenclatures, it would be very simple.  However, this is an example of a deceivingly simple 
text which is totally embedded in culture.  The following table summarizes the most challenging areas of the 
translation. 
 
Table 2. The most challenging areas of the translation 
 
English Italian Comment 
Factor 1 Cognitive 
Confidence 
 
 
“I have a poor memory” 
 
“I have little confidence in my 
memory” for ( actions, places, 
words and names)” 
 
 
 
 
“Ho poca memoria” 
This is not translated directly. 
 
 
“Ho poca fiducia nella mia 
capacità di ricordare…..” 
This is not translated directly. 
 
 
 
 
Culturally the use of the Italian word for ‘poor’ would have 
negative connotations and imply a value judgement while the goal 
is to illicit information. 
 
The Italian word “confidenza” which would be the direct 
translation based on cognate theory, has a completely different 
meaning.  Direct translation would be “I have little faith in my 
ability to establish an intimate relationship with my self”. 
 
      Factor 2 Positive Beliefs 
“Worrying helps me to get 
things sorted out in my mind.” 
 
“Worrying helps me to cope.” 
 
 
 
“Preoccuparmi mi aiuta a 
sistemare le cose nella mia 
mente.” 
“Preoccuparmi mi aiuta a 
fronteggiare situazioni 
disastrose.” 
 
 
 
The tendency would be to use the word ‘organize’ but the word 
‘organize’ in Italian is almost always used to refer to the planning 
of an event or meeting. 
Here is an example of cultural differences.  The English meaning 
‘cope’ ranges from the ability to “contend or strive especially on 
even terms or with success” 
(http://www.thefreedictionary.com/cope).  Another definition is 
“he process of contending with life difficulties in an effort to 
overcome or work through them”. http://medical-
dictionary.thefreedictionary.com/Coping It would seem to the 
native English speaker that the use of the word ‘disastrosa’ is very 
emphatic, whereas in Italian culture it is considered less so. 
Factor 3 Cognitive Self-
Consciousness 
 
 
 
“I monitor my thoughts.” 
 
 
 
 
 
“Controllo i miei pensieri.” 
 
 
 
Monitor: to observe and check the progress or quality of 
(something) over a period of time (Oxford Dictionaries.com, 
2015). 
The word ‘controllo’ is a false cognate in English.  It means 
inspect, check, keep a close watch on in Italian 
(http://www.collinsdictionary.com/dictionary/italian-
english/controllare) 
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Factor 4 Uncontrollability and 
Danger 
 
“My worrying could make me 
go mad.” 
 
 
  
 “Le mie preoccupazioni mi 
possono fare diventare matto.” 
mad/insane/crazy= matto/pazzo 
(Oxford Dictionaries, 2015) 
 
The literal meaning and cultural meaning of the words “mad” and 
“crazy” are the same. 
The definition of “mad” is “insane or angry”; the definition of 
“crazy” is “insane or mad” (Merriam-Webster, 2015).  The use of 
“mad” to express the state of being angry is more frequent than the 
use of “mad” to express “crazy”.   And again in American English, 
“crazy” occurs more frequently than “mad”.  What this means is 
that the authors, who are from the U.K., chose to use the word 
“mad” to express “insane”; perhaps the vernacular use of “mad” is 
softer than “insane”.  This brings up an observation on the cultural 
stigma of being mentally ill; whether it is better to label oneself in 
the vernacular or with a higher register medical term. 
In Italy there is still a stigma attached to those who seek 
psychological help. Consequently the word “matto” was chosen 
because it is slightly lighter than “pazzo” even though they have 
the same meaning. 
Here is an example of words with identical meanings according to 
the dictionary but with slightly different shades of meaning 
according to region. 
Factor 5 Need to Control 
thoughts 
 
“Not being able to control my 
thoughts is a sign of 
weakness” 
 
 
“Non essere in grado di 
controllare i propri pensieri e’ un 
segno di debolezza“ 
 
 
‘Control’(“Controllare”) in this sense has the same meaning in 
Italian as in English:to dominate, to have something under control 
http://www.dizionario-italiano.org/Controllare. One would 
question whether the phrase used by the authors of the test is 
culturally bound.  It is common knowledge that the British culture  
historically promoted ‘keeping a stiff upper lip’ and would prefer 
not to be considered weak.(Telegraph, April 19, 2015) <one could 
perhaps extend that to the U.S. and other English-speaking 
countries.  In Italy perhaps the definition of ‘weakness’ is different 
and not as frightening. 
 
 
3.3.7. Validity of translation 
 
The translators of the MCQ-30 utilized the above analytical items. They also utilized the a list, taken from 
Larson, (1984).  The five areas included: comparison with the English MCQ-30 text, back-translation from Italian 
back to English, comprehension checks, readability and naturalness and consistency tests.  In addition to that, as 
noted in the above table, cultural differences were considered as a main question of importance.  The differences in 
communication styles, use of idomatic structures, strength of words and innuendos were analyzed in the comparison. 
They also considered the fact that text reception also depends on the receivers, their expectations, social 
background, world knowledge and communicative needs (Nord, 1991, 2005 p. 17).  The final test was the 
comparison of the actual statistical results.  Satisfactory internal consistency, convergent validity, and good test-
retest reliability were noted. Also, the five-factor solution was confirmed.  (Quattropani, et. al, 2014). Therefore 
because the MCQ-30 has good psychometric properties it was used in this clinical research.  The authors attest to the 
concept of the “faithful translation” which according to (Newmark, pp. 45-47, 1988) attempted to produce the 
precise contextual meaning of the original within the constraints of the Italian target language structures. 
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3.4. Hospital Anxiety and Depression Scale 
This is a 14-item self-reporting scale that is divided into two dimensions, each composed of 7 items. The two 
subscales provide a measure of anxiety (HADS-A) and depression (HADS-D). The HADS is specifically designed 
for assessing physically ill patients and is used with medical outpatients. Respondents choose one from four 
responses to each item. Their responses are then summed within dimensions and a total score for each dimension, as 
well as both dimensions, are obtained. Scores can range from 0 to 21 for each subscale with high scores indicating 
higher levels of anxiety and depression. According to the authors of the HADS, scores for the anxiety dimension and 
the depression dimension can be categorized as follows: 0–7, normal; 8–10, mild; 11–14, moderate; 15–21, severe. 
Moreover, scores for the entire scale assess overall emotional distress and range from 0-42, with higher scores 
indicating more distress. The HADS has been employed among a wide range of clinical groups. Results of an Italian 
study with a sample of breast cancer patients indicated a total score for both dimensions of 10 points, 10 being the 
cut-off score  for psychological distress (Costantini et al., 1999). Reliability of the two factors in this present sample 
was good, with Cronbach’s D of 0.73 for depression scale and 0.81 for anxiety scale. 
3.5.  Data analysis 
Data obtained from this research was checked and subsequently analyzed by a descriptive statistical analysis and 
modeling. Descriptive statistics were calculated for MCQ-30, HADS, and for sociodemographic and medical 
information. Pearson correlation coefficients were calculated to examine the bivariate associations among study 
variables. 
4. Results 
Table 3 shows the mean scores, and zero-order correlations for all the observed variables. Regarding 
metacognitive factors, results showed that negative beliefs had the strongest correlation both with anxiety (r = 0.74; 
p < 0.01) and depression (r = 0.58; p < 0.01). There were no other significant correlations between the metacognitive 
factors and anxiety or depression, with the exception of cognitive confidence and positive beliefs factors. Cognitive 
confidence showed low correlation coefficients with anxiety (r = 0.24; p < 0.01) and depression (r = 0.22; p < 0.01). 
Positive beliefs had a low significant correlation with anxiety (r = 0.20; p < 0.05) but not with depression. The total 
score of MCQ were positively related with all the other observed variables. Correlation coefficients were low to 
high, with the lowest for depression (r = 0.32; p < 0.01). Finally, the total score of HADS showed significant and 
positively correlations with negative beliefs (r = 0.69; p < 0.01) and cognitive confidence (r = 0.26; p < 0.01), but 
not with the other metacognitive factors. 
 
Table 3. Descriptive statistics (mean with standard deviations in parentheses) and zero-order correlations for all the variable observed 
Variable M (SD) 1 2 3 4 5 6 7 8 
1. HADS Anxiety 6.88 (4.32)         
2. HADS Depression 5.76 (3.70) 0.69**        
3. HADS total score 12.42 (7.49) 0.93** 0.90**       
4. MCQ-30 Positive beliefs 10.24 (4.57) 0.20* 0.01 0.12      
5. MCQ-30 Negative beliefs 12.84 (4.53) 0.74** 0.58** 0.69** 0.12     
6. MCQ-30 Cognitive 
confidence 10.54 (4.27) 0.24** 0.22** 0.26** 0.10 0.19*    
7. MCQ- 30 Need to control 15.06 (3.47) 0.09 0.05 0.10 0.26** 0.28* 0.00   
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thoughts 
8. MCQ-30 Cognitive self-
consciousness  18.71 (3.38) 0.06 -0.02 0.05 0.19* 0.14 -0.13 0.43**  
9. MCQ-30 total score 67.39(11.54) 0.50** 0.32** 0.46** 0.62** 0.64** 0.45** 0.64** 0.51** 
HADS, Hospital anxiety and depression scale; MCQ-30, short version of the Metacognitions Questionnaire. 
*p < 0.05. 
** p < 0.001. 
 
5. Conclusion and Recommendations 
In this study, our aim was to explore the role of metacognitions in cancer patients undergoing chemotherapy. The 
hypothesis was to explore the association between the metacognitive factors and emotional distress (anxiety and 
depression).  
Consistent with present studies on metacognitions and emotional distress (Spada et al., 2008a,b; Wells, 2009) 
some dysfunctional metacognitive beliefs were positively associated with both anxiety and depression (Table 3). 
Specifically, the negative beliefs about worry concerning uncontrollability and danger showed a strong correlation 
with anxiety. During chemotherapy, the extent to which a patient thinks that perseverative thinking is uncontrollable 
and dangerous is strongly related to the presence of a negative emotion, such as anxiety. Negative beliefs were also 
related to depression, but with a lower intensity. It seems that the presence of depression symptoms can be mediated 
by other characteristics of the patient.  
Another metacognitive factor, cognitive confidence, was related both to anxiety and depression but with a low 
intensity. Cognitive confidence that reflects the levels of cognitive esteem in attention and memory contributes to 
emotional distress limiting the choice of effective coping strategies available to the patient in chemotherapy. 
In this regard, positive beliefs about worry showed a low relation to anxiety but not depression. It seems that the 
extent to which a patient believes that perseverative thinking is useful can be associated only with the presence of 
anxiety symptoms. 
Beliefs about the need to control thoughts did not relate with anxiety or depression. It is possible to hypothesize 
that the great preoccupation and anxiety of patients in chemotherapy cause them to give less relevance to the need to 
control all their thoughts. 
Finally, cognitive self-consciousness that reflects the tendency to focus attention on thought processes was not 
related to negative emotions. Consistently with previous studies on metacognitions, the tendency to monitor one’s 
own thoughts and focus attention inwards has a marginal role in the metacognitive model of psychopathology. 
The present study is a first exploration of the role of metacognition in cancer patients undergoing chemotherapy. 
However, there are a number of limitations that should be addressed by future research. A major limitation was the 
heterogeneous characteristics of the sample (e.g., different types of tumor and time elapsed after diagnosis; the time 
that patients underwent chemotherapy (Massie 2004; Mitchell et al., 2011). Moreover, the percentage of males in the 
sample was less than that of females and results can be influenced by this. In fact, past studies showed that women 
report more distress than men due to anxiety and depression (Oliffe 2008; McLean 2009). For these reasons, this 
study needs replication to further examine the role of some medical aspects of cancer.  
 If confirmed by future research, results of this study would have implications in clinical practice. In literature 
there is confusion about what “psychological intervention” means in  clinical practice. Starting from the relationship 
between metacognitions and negative emotions, “psychological intervention” based on the metacognitive approach 
(Wells, 2007, 2009) could have positive effects on patients undergoing chemotherapy. 
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